BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 16174167)

  • 1. Impact of sentinel lymph node biopsy on lymphedema following breast cancer treatment.
    Soran A; Aydin C; Harlak A; Vogel VG; Johnson R
    Breast J; 2005; 11(5):370-1. PubMed ID: 16174167
    [No Abstract]   [Full Text] [Related]  

  • 2. Axillary reverse mapping to prevent lymphedema after breast cancer surgery: defining the limits of the concept.
    Khan SA
    J Clin Oncol; 2009 Nov; 27(33):5494-6. PubMed ID: 19826108
    [No Abstract]   [Full Text] [Related]  

  • 3. Micrometastases in sentinel lymph nodes: few data make for hard decisions.
    Rowan K
    J Natl Cancer Inst; 2009 Oct; 101(20):1374-6. PubMed ID: 19797724
    [No Abstract]   [Full Text] [Related]  

  • 4. Axillary reverse mapping: mapping and preserving arm lymphatics may be important in preventing lymphedema during sentinel lymph node biopsy.
    Boneti C; Korourian S; Bland K; Cox K; Adkins LL; Henry-Tillman RS; Klimberg VS
    J Am Coll Surg; 2008 May; 206(5):1038-42; discussion 1042-4. PubMed ID: 18471751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Axillary reverse mapping in breast cancer: a new microsurgical lymphatic-venous procedure in the prevention of arm lymphedema.
    Casabona F; Bogliolo S; Ferrero S; Boccardo F; Campisi C
    Ann Surg Oncol; 2008 Nov; 15(11):3318-9. PubMed ID: 18709416
    [No Abstract]   [Full Text] [Related]  

  • 6. Arm morbidity following sentinel lymph node biopsy or axillary lymph node dissection: a study from the Danish Breast Cancer Cooperative Group.
    Husted Madsen A; Haugaard K; Soerensen J; Bokmand S; Friis E; Holtveg H; Peter Garne J; Horby J; Christiansen P
    Breast; 2008 Apr; 17(2):138-47. PubMed ID: 17928226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Low invasion in sentinel lymph node according to the European Working Group In Breast Screening Pathology (EWGBSP) recommendations and non sentinel invasion risk in breast cancer].
    Gauthier T; Fermeaux V; Mollard J; Aubard Y
    Gynecol Obstet Fertil; 2009 Jun; 37(6):481-7. PubMed ID: 19457697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of direct oil contrast lymphography of upper limb lymphatics traversing the axilla -- a lesson from the past -- contribution to the concept of axillary reverse mapping.
    Pavlista D; Eliska O
    Eur J Surg Oncol; 2012 May; 38(5):390-4. PubMed ID: 22336143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Axillary recurrence in women with a negative sentinel lymph node and no axillary dissection in breast cancer.
    Palesty JA; Foster JM; Hurd TC; Watroba N; Rezaishiraz H; Edge SB
    J Surg Oncol; 2006 Feb; 93(2):129-32. PubMed ID: 16425295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-axillary breast cancer recurrences after sentinel node biopsy.
    van Rijk MC; Nieweg OE; Valdés Olmos RA; Rutgers EJ; Hoefnagel CA; Kroon BB
    J Surg Oncol; 2005 Dec; 92(4):292-8. PubMed ID: 16299804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can axillary reverse mapping avoid lymphedema in node positive breast cancer patients?
    Tausch C; Baege A; Dietrich D; Vergin I; Heuer H; Heusler RH; Rageth C
    Eur J Surg Oncol; 2013 Aug; 39(8):880-6. PubMed ID: 23735162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of the axilla after the finding of a positive sentinel lymph node: a proposal for an evidence-based risk-adapted algorithm.
    Evans SB; Gass J; Wazer DE
    Am J Clin Oncol; 2008 Jun; 31(3):293-9. PubMed ID: 18525310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphedema following axillary lymph node dissection for breast cancer.
    Sakorafas GH; Peros G; Cataliotti L; Vlastos G
    Surg Oncol; 2006 Nov; 15(3):153-65. PubMed ID: 17187979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of axillary reverse mapping related factors on lymphedema in breast cancer patients.
    Ikeda K; Ogawa Y; Kajino C; Deguchi S; Kurihara S; Tashima T; Goto W; Nishiguchi Y; Tokunaga S; Fukushima H; Inoue T
    Eur J Surg Oncol; 2014 Jul; 40(7):818-23. PubMed ID: 24768416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early adoption and disturbing disparities in sentinel node biopsy in breast cancer.
    Edge SB
    J Natl Cancer Inst; 2008 Apr; 100(7):449-50. PubMed ID: 18364503
    [No Abstract]   [Full Text] [Related]  

  • 16. Is axillary dissection needed in node-positive breast cancer?
    Greenberg CC; Bafford AC; Golshan M
    Expert Rev Anticancer Ther; 2008 Feb; 8(2):195-8. PubMed ID: 18279060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of frozen-section analysis of sentinel lymph node and lumpectomy margin status on reoperation rates in patients undergoing breast-conservation therapy.
    McLaughlin SA; Ochoa-Frongia LM; Patil SM; Cody HS; Sclafani LM
    J Am Coll Surg; 2008 Jan; 206(1):76-82. PubMed ID: 18155571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intramammary lymph node metastasis of breast cancer after sentinel node biopsy: two cases and a review of the literature.
    Araújo C; Fougo JL
    Eur J Surg Oncol; 2009 Dec; 35(12):1354. PubMed ID: 19592195
    [No Abstract]   [Full Text] [Related]  

  • 19. [Evaluation of sentinel lymph node biopsy in detection of axillary lymph node metastasis in breast cancer].
    Zhang JG; Zhong L; Li CL
    Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):235-6. PubMed ID: 17649646
    [No Abstract]   [Full Text] [Related]  

  • 20. Risk factors for non-sentinel lymph node metastases in breast cancer patients with positive sentinel lymph nodes.
    Zhang T; Wang H; Chen BP; Zhang HS; Wei XL; Fu Y; Li Z; Hu GK
    Chin Med J (Engl); 2008 Oct; 121(20):2107-9. PubMed ID: 19080285
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 21.